Tag
14 articles
MIT researchers found that AI explainability tools in healthcare produce different results based on user expertise, highlighting the need for adaptive interfaces.
Cambridge startup Qureight has raised $20 million to build a universal AI model for chest imaging, aiming to accelerate drug trials and clinical research.
This article explains the advanced AI concept of medical reasoning in healthcare systems, exploring how large language models are being trained to diagnose and reason like medical professionals.
Bunkerhill Health has raised $25 million in Series B funding to deploy AI agents in hospitals, aiming to solve the challenge of implementing AI in real-world healthcare environments.
OpenAI introduces Genebench-Pro, a new benchmark for evaluating large language models' biological and medical understanding capabilities. The tool aims to advance AI applications in healthcare and scientific research.
AdventHealth partners with OpenAI to implement ChatGPT for Healthcare, aiming to streamline workflows and enhance patient care through AI automation.
Corti launches a no-equity accelerator for healthcare AI startups, offering access to its Symphony model and regulatory support amid rising EU AI regulations.
BioticsAI CEO Robhy Bustami discusses how the company has navigated FDA regulations and maintained team motivation while building healthcare AI solutions.
Meta's Muse Spark AI model requested access to users' raw health data and provided medically questionable advice, raising serious privacy and safety concerns.
Anthropic has acquired Coefficient Bio, a stealth biotech startup founded just eight months ago, in a $400 million all-stock deal. The acquisition brings in a team of fewer than 10 former Genentech researchers, signaling Anthropic's expansion into healthcare AI.
Corti's new Symphony AI outperforms OpenAI and Anthropic in medical coding, leveraging peer-reviewed research to treat coding as a reasoning task.
OpenAI announces the launch of the OpenAI Foundation, committing at least $1 billion to disease research, economic opportunity, AI resilience, and community programs.
